Biodrone News
Reyon and MDimune Sign CDVs-Mediated mRNA Delivery Partnership
May 13, 2021 Reyon and MDimune has announced the signing of a partnership focused on mRNA delivery for antivirus vaccine and rare genetic disorder.
Research Collaboration with Navigo Proteins on Affilin®-Mediated Targeting of EVs
May 11, 2021 Navigo Proteins and MDimune announced a technology collaboration to achieve tissue-targeting of extracellular vesicles (EVs), Affilin®-mediated delivery of CDVs specifically to solid tumor targets.
Partnership with Evercyte for developing tumor-targeting EVs
Apr 5, 2021 MDimune and Evercyte GmbH announced a strategic collaboration to develop tumor-targeted drug delivery by combining their technologies.
Service Agreement with ExoNanoRNA to Advance Targeted Drug Delivery for Cancer
Mar 15, 2021 ExonanoRNA and MDimune have entered into a service agreement to develop targeted siRNA therapy in oncology applications.
Korean Researchers Received MDimune’s 1st BioDrone® Award
Oct 30, 2020 MDimune announced the signing of research agreements with Pohang University of Science and Technology (POSTECH), Konkuk University, and Catholic University.
MDimune Selected by Lonza to the Startup Creasphere Program
Oct 28, 2020 Plug and Play, headquartered in Silicon Valley, California, announced that MDimune will be partnering with Lonza. MDimune is among 11 Batch 5 startups to join the global startup incubation program ‘Startup Creasphere’.
Received “Best Cell Therapy Technology of the Year” award
Oct 26, 2020 BioDrone® platform technology was awarded the “Best Cell Therapy Technology of the Year” at the annual Cell Therapy World Asia 2020 conference.
Collaboration with EV Experts at PMU
Apr 30, 2020 MDimune Signed a Research Collaboration Agreement with Paracelsus Medical University for EV Therapeutics Development.